Clinical Trial Update: Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous immunoglobulin G (IGIV-C) for efficacy and safety in corticosteroid-dependent generalized myasthenia gravis; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• IGIV-C

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-26